← FDA Drug Approvals (Drugs@FDA)
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2016-04-01
Drug application
- FDA Application #
ANDA078709- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
- Generic name
- Glimepiride
- Active ingredients
- GLIMEPIRIDE; ROSIGLITAZONE MALEATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TEVA PHARMS USA
- First approval
- 2016-04-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown